CA9 and hereditary clear cell renal cell carcinoma: The MAbs raised against cellular CA IX have been employed for the identification of CA IX in renal cell carcinoma and other tumor cells, as well as targeting tumor cells by an enhanced internalization of antibody-bound CA IX [9].